Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. 1994

P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
Orion Corp., Orion-Farmos, Orion Research, Espoo, Finland.

The binding of a new calcium sensitizer, levosimendan, to human cardiac troponin C (cTnC) is described. Fluorescence studies done on dansylated recombinant human cTnC and a site-directed mutant showed that levosimendan modulated the calcium-induced conformational change in cTnC, and revealed the role of Asp-88 in the binding of the drug to the NH2-terminal domain of cTnC. Furthermore, NMR studies performed on the NH2-terminal fragment of cTnC showed a spatial proximity between levosimendan and Met81, Met85, and Phe77 in the drug-protein complex. These data were used to build an optimized model of the drug-protein complex, in which levosimendan binds cTnC at the hydrophobic pocket of the NH2-terminal domain. The role of the binding of levosimendan to cTnC in the pharmacological action of this drug in vivo is discussed.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011522 Protons Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. Hydrogen Ions,Hydrogen Ion,Ion, Hydrogen,Ions, Hydrogen,Proton
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial

Related Publications

P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
June 1990, The Journal of biological chemistry,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
November 2016, Biochemistry,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
March 2001, The Journal of biological chemistry,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
February 2004, European journal of pharmacology,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
November 1978, Biochemistry,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
June 1990, The Journal of biological chemistry,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
October 1977, Journal of molecular biology,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
October 1980, The Journal of biological chemistry,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
June 1990, The Journal of biological chemistry,
P Pollesello, and M Ovaska, and J Kaivola, and C Tilgmann, and K Lundström, and N Kalkkinen, and I Ulmanen, and E Nissinen, and J Taskinen
January 1976, FEBS letters,
Copied contents to your clipboard!